SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Article References

REIS, A.F.; MIRANDA, W.L.  and  CHACRA, A.R.. Low levels of sex hormone-binding globulin and hyperproinsulinemia as markers of increased pancreatic ß-cell demand in men. Braz J Med Biol Res [online]. 1998, vol.31, n.12, pp. 1545-1551. ISSN 1414-431X.  http://dx.doi.org/10.1590/S0100-879X1998001200006.

    1. Rosner W (1990). The functions of corticosteroid-binding globulin and sex hormone-binding globulin; recent advances. Endocrine Reviews, 11: 80-91.

    [ Links ]

    2. Plymate SR, Matej LA, Jones RE & Friedl KE (1988). Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. Journal of Clinical Endocrinology and Metabolism, 67: 460-464.

    [ Links ]

    3. Preziosi P, Barrett-Connor E, Papoz L, Roger M, Saint-Paul M, Nahoul K & Simon D (1993). Interrelation between plasma sex hormone-binding globulin and plasma insulin in healthy adult women: the telecom study. Journal of Clinical Endocrinology and Metabolism, 76: 283-287.

    [ Links ]

    5. Caprio S, Plewe G, Diamond MP, Simonson DC, Boulware SD, Sherwin RS & Tamborlane WV (1989). Increased insulin secretion in puberty: a compensatory response to reductions in insulin sensitivity. Journal of Pediatrics, 114: 963-967.

    [ Links ]

    6. Haffner SM, Valdez RA, Morales PA, Hazuda HP & Stern MP (1993). Decreased sex hormone-binding globulin predicts noninsulin-dependent diabetes mellitus in women but not in men. Journal of Clinical Endocrinology and Metabolism, 77: 56-60.

    [ Links ]

    7. Andersson B, Marin P, Lissner L, Vermeulen A & Björrntorp P (1994). Testosterone concentrations in women and men with NIDDM. Diabetes Care, 17: 405-411.

    [ Links ]

    8. Haffner SM, Karhapää P, Mykkänen L & Laakso M (1994). Insulin resistance, body fat distribution, and sex hormones in men. Diabetes, 43: 212-219.

    [ Links ]

    9. Shimizu M, Kawazu S, Tomono S, Ohno T, Utsugi T, Kato N, Ishii C, Ito Y & Murata K (1996). Age-related alteration of pancreatic ß-cell function: Increased proinsulin and proinsulin-to-insulin molar ratio in elderly, but not in obese subjects without glucose intolerance. Diabetes Care, 19: 8-11.

    [ Links ]

    10. Haffner SM, Gonzalez C, Mykkänen L & Stern M (1997). Total immunoreactive proinsulin, immunoreactive insulin and specific insulin in relation to conversion to NIDDM: the Mexico City diabetes study. Diabetologia, 40: 830-837.

    [ Links ]

    11. Røder ME, Knip M, Hartling SG, Karjalainen J, Akerblom HK, Binder C & The Childhood Diabetes in Finland Study Group (1994). Disproportionately elevated proinsulin levels precede the onset of insulin-dependent diabetes mellitus in siblings with low first phase insulin responses. Journal of Clinical Endocrinology and Metabolism, 79: 1570-1575.

    [ Links ]

    12. Kahn SE, Leonetti DL, Prigeon RL, Boyko EJ, Bergstrom RW & Fujimoto WY (1995). Proinsulin as a marker for the development of NIDDM in Japanese-American men. Diabetes, 44: 173-179.

    [ Links ]

    13. Dalbosco IS, Coifman R, Moisés RCS, Vieira JGH & Russo EMK (1995). Influência da obesidade e da glicemia nos níveis de pró-insulina durante o teste oral de tolerância à glicose. Arquivos Brasileiros de Endocrinologia e Metabologia, 39: 89-93.

    [ Links ]

    15. Fendri S, Arlot S, Marcelli JM, Dubreuil A & Lalau JD (1994). Relationship between insulin sensitivity and circulating sex hormone-binding globulin levels in hyperandrogenic obese women. International Journal of Obesity, 18: 755-759.

    [ Links ]

    16. Yki-Järvinen H, Mäkimattila S, Utriainen T & Rutanen EM (1995). Portal insulin concentrations rather than insulin sensitivity regulate serum sex hormone-binding globulin and insulin-like growth factor binding protein 1 in vivo. Journal of Clinical Endocrinology and Metabolism, 80: 3227-3232.

    [ Links ]

    17. Hamilton-Fairley D, White D, Griffiths M, Anyaoku V, Koistinen R, Seppälä M & Franks S (1995). Diurnal variation of sex hormone binding globulin and insulin-like growth factor binding protein-1 in women with polycystic ovary syndrome. Clinical Endocrinology, 43: 159-165.

    [ Links ]

    18. Peiris LN, Stagner JI, Plymate SR, Vogel RL, Heck M & Samols E (1993). Relationship of insulin secretory pulses to sex hormone-binding globulin in normal men. Journal of Clinical Endocrinology and Metabolism, 76: 279-282.

    [ Links ]

    19. Pasquali R, Casimirri F, De Iasio R, Mesini P, Boschi S, Chierici R, Flamia R, Biscotti M & Vicennati V (1995). Insulin regulates testosterone and sex hormone-binding globulin concentrations in adult normal weight and obese men. Journal of Clinical Endocrinology and Metabolism, 80: 654-658.

    [ Links ]

    20. Lindstedt G, Lundberg PA, Lapidus L, Lundgren H, Bengtsson C & Björntorp P (1991). Low sex-hormone-binding globulin concentration as independent risk factor for development of NIDDM: 12-yr follow-up of population study of women in Gothenburg, Sweden. Diabetes, 40: 123-128.

    [ Links ]

    21. Loukovaara M, Carson M & Adlercreutz H (1995). Regulation of sex hormone-binding globulin secretion and gene expression by cycloheximide in vitro. Journal of Steroid Biochemistry and Molecular Biology, 54: 141-146.

    [ Links ]

    22. Haffner SM, Mykkänen L, Valdez RA, Stern MP, Holloway DL, Monterrosa A & Bowsher RR (1994). Disproportionately increased proinsulin levels are associated with the insulin resistance syndrome. Journal of Clinical Endocrinology and Metabolism, 79: 1806-1810.

    [ Links ]

    23. Yudkin JS, Denver AE, Mohamed-Ali V, Ramaiya KL, Nagi DK, Goubet S, McLarty DG & Swai A (1997). The relationship of concentration of insulin and proinsulin-like molecules with coronary heart disease prevalence and incidence. Diabetes Care, 20: 1093-1100.

    [ Links ]

    24. Warren-Perry MG, Manley SE, Ostrega D, Polonsky K, Mussett S, Brown P & Turner RC (1997). A novel point mutation in the insulin gene giving rise to hyperproinsulinemia. Journal of Clinical Endocrinology and Metabolism, 82: 1629-1631.

    [ Links ]

    25. Horvitz DL, Starr JI, Mako ME, Blackard WG & Rubenstein AH (1975). Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood. Journal of Clinical Investigation, 55: 1278-1283.

    [ Links ]

    26. Glauber HS, Henry RR, Wallace P, Frank BH, Gallowaw JA, Cohen RM & Olefsky JM (1987). The effects of biosynthetic human proinsulin on carbohydrate metabolism in non-insulin-dependent diabetes mellitus. New England Journal of Medicine, 316: 443-449.

    [ Links ]

    27. Robbins DC, Tager HS & Rubenstein AH (1984). Biologic and clinical importance of proinsulin. New England Journal of Medicine, 310: 1165-1175.

    [ Links ]

    28. Haffner SM, Miettinen H & Stern MP (1997). The homeostasis model in the San Antonio heart study. Diabetes Care, 20: 1087-1092.

    [ Links ]

    29. Ludvik B, Nolan JJ, Baloga J, Sacks D & Olefsky J (1995). Effect of obesity on insulin resistance in normal subjects and patients with NIDDM. Diabetes, 44: 1121-1125.

    [ Links ]

    30. Banerji MA, Chaiken RL, Gordon D, Kral JG & Lebovitz HE (1995). Does intra-abdominal adipose tissue in black men determine whether NIDDM is insulin-resistant or insulin-sensitive? Diabetes, 44: 141-146.

    [ Links ]

    31. Phillips GB (1993). Relationship between serum sex hormones and the glucose-insulin-lipid defect in men with obesity. Metabolism, 42: 116-120.

    [ Links ]